Madrigal Pharmaceuticals, Inc. MDGL Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s net change in cash?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported net change in cash of $28.41M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s net change in cash decreased by 66.0% year-over-year, from $83.63M to $28.41M.
- What does net change in cash mean?
- The total increase or decrease in the company's cash position during the period.
- How do you interpret net change in cash?
- An increase indicates a net build-up of liquidity, while a decrease indicates cash burn or capital deployment exceeding inflows.
- How does net change in cash compare across companies?
- Common across all public companies; critical for assessing runway in pre-revenue or growth-stage firms.